Lithium-Driven Exosomal Wnt10a Secretion Enhances Osteogenes
2026-06-03
This study reveals how lithium promotes osteogenesis by facilitating Rab11a-dependent exosomal Wnt10a secretion and activating β-catenin signaling in bone mesenchymal stem cells (BMSCs). The findings illuminate a precise molecular mechanism for bone regeneration, suggesting new avenues for engineering exosomes and small-molecule interventions in regenerative medicine.
siRNA Nanoparticles Target TDRD9 to Mitigate Bacterial Lung
2026-06-02
This study develops a hyaluronic acid sodium salt-coated siRNA nanoparticle platform that targets Tudor domain-containing protein 9 (TDRD9) in neutrophils, thereby promoting cuproptosis and reducing Pseudomonas aeruginosa-induced lung injury in preclinical models. The findings elucidate a novel immune modulation strategy and highlight the translational potential of ECM-inspired delivery vehicles in bacterial pneumonia.
CDK4 Drives Cap-Dependent Translation via 4E-BP1 Phosphoryla
2026-06-02
This study identifies cyclin-dependent kinase 4 (CDK4) as a novel kinase that phosphorylates the translational repressor 4E-BP1, enabling cap-dependent translation during the mitosis-G1 transition. The findings revise established models of cell cycle-regulated translation and offer new strategies for targeting oncogenic protein synthesis in contexts resistant to mTOR inhibition.
Micellar Spectrofluorimetry for Simultaneous Alfuzosin HCl A
2026-06-01
This study introduces a sensitive micellar spectrofluorimetric method to simultaneously quantify Alfuzosin HCl and vardenafil hydrochloride in pharmaceutical and biological samples. By leveraging a micellar matrix to enhance fluorescence, the method offers high sensitivity, linearity, and practical utility for benign prostatic hyperplasia and lower urinary tract research.
Biotin Azide: Precision Biotinylation for Click Chemistry Wo
2026-06-01
Biotin Azide enables highly selective, bio-orthogonal labeling of alkynylated biomolecules in both fundamental and translational research. This article details how to leverage its unique properties for advanced protein, DNA, and lipid signaling studies—highlighting robust protocols, troubleshooting, and insights from recent cancer signaling breakthroughs.
Fluorouracil (Adrucil): Mechanistic Precision and Resistance
2026-05-31
Explore the advanced mechanism of Fluorouracil (5-Fluorouracil, Adrucil) in colon and breast cancer research. This article uniquely examines multidrug resistance dynamics and practical assay strategies, offering deeper insight than existing resources.
High-Dose Maternal Tamoxifen Induces Developmental Malformat
2026-05-30
This study demonstrates that a single high dose of tamoxifen in pregnant mice can cause dose-dependent craniofacial and limb malformations in offspring. The findings underscore the importance of dose selection and timing when using tamoxifen in developmental and genetic studies.
FLOT1–FOSL2–EphA2 Axis Regulates Microglial Polarization in
2026-05-29
This study identifies the FLOT1–FOSL2 interaction as a key regulator of EphA2 transcription, which drives pro-inflammatory microglial polarization and neuroinflammation in Alzheimer's disease. By elucidating this signaling axis, the research provides mechanistic insight into microglial dynamics and highlights new intervention points for modulating cognitive decline.
Sodium Overload Disrupts Mitochondrial Metabolism in NECSO C
2026-05-29
The recent work by Qiao et al. reveals that sodium influx through TRPM4 channels disrupts mitochondrial energy metabolism, directly triggering necrosis by sodium overload (NECSO). Their mechanistic insights clarify how mitochondrial depolarization and energy failure underlie sodium-driven cell death, with implications for research on ischemia, organ failure, and ion homeostasis.
Phebestin as a Potent Aminopeptidase Inhibitor Against Malar
2026-05-28
This study demonstrates that phebestin, a bestatin-related aminopeptidase inhibitor, exhibits nanomolar efficacy against both chloroquine-sensitive and resistant Plasmodium falciparum strains with low cytotoxicity. The findings highlight phebestin's mechanistically distinct antimalarial potential and inform future therapeutic strategies targeting parasite-specific peptidases.
Early Life Adversity Disrupts Innate Defense via Oxytocin Lo
2026-05-28
Tan et al. reveal that early life adversity (ELA), modeled by postnatal social deprivation in mice, leads to impaired visually evoked innate defensive responses through reduced oxytocin signaling in the superior colliculus. This mechanistic insight advances understanding of how ELA shapes neural circuits relevant to fear processing and highlights molecular targets for future intervention.
Trifluoperazine 2HCl: Enhancing Dopaminergic Assays in Resea
2026-05-27
This article provides a scenario-driven guide for biomedical researchers seeking reliable solutions for dopaminergic signaling pathway studies using Trifluoperazine 2HCl (SKU B1397). It addresses real laboratory challenges—ranging from reproducibility in cell viability assays to product selection criteria—while emphasizing protocol optimization and validated data. Researchers will gain actionable insights for achieving robust, interpretable results in neuropharmacology and cancer biology workflows.
Anagliptin (SK-0403): Precision DPP-4 Inhibition for Vascula
2026-05-27
Anagliptin (SK-0403) propels diabetes and vascular research beyond glycemic control, uniquely enabling combined DPP-4 inhibition and direct vascular modulation. This article details experimental workflows, protocol parameters, and troubleshooting strategies rooted in the latest mechanistic insights—empowering researchers to interrogate Kv channel and SERCA pump activity with confidence.
Electrostatic Partitioning and Precision: Cy5 Maleimide in A
2026-05-26
Explore how Cy5 maleimide (non-sulfonated) enables next-generation, electrostatically informed protein labeling for demanding fluorescence applications. This article reveals practical assay strategies and interprets cutting-edge research on molecular partitioning, going beyond standard protocol guidance.
Mitoxantrone HCl: DNA Topoisomerase II Inhibitor in Oncology
2026-05-26
Mitoxantrone HCl stands out as a DNA topoisomerase II inhibitor with dual roles in DNA damage and nuclear receptor modulation, opening new avenues for resistance-overcoming cancer research. Its versatility spans leukemia, multiple sclerosis, and apoptosis induction in stem cells, with recent studies highlighting its unique allosteric targeting of ERα.
466 records 17/32 page Previous Next First page 上5页 1617181920 下5页 Last page